IL36G
IL36G is a gene that encodes the protein IL-36 gamma, a member of the Interleukin family of cytokines. These proteins are involved in the immune response and inflammation processes in the body. IL36G is particularly associated with skin diseases, such as psoriasis and eczema, and other inflammatory conditions.
Function[edit]
The IL36G gene encodes the IL-36 gamma protein, which is a part of the IL-36 subfamily within the larger Interleukin-1 cytokine family. This protein is primarily expressed in the skin, particularly in keratinocytes, and plays a crucial role in the immune response and inflammation. It is involved in the activation of NF-kappaB and MAPK signaling pathways, which are essential for the production of pro-inflammatory cytokines.
Clinical Significance[edit]
Mutations in the IL36G gene have been associated with the development of several inflammatory skin diseases. These include generalized pustular psoriasis (GPP), a severe form of psoriasis, and eczema, a condition characterized by itchy, red, and inflamed skin. Studies have also suggested a role for IL36G in other inflammatory conditions, such as rheumatoid arthritis and inflammatory bowel disease.
Research[edit]
Research into the IL36G gene and its encoded protein is ongoing, with a focus on understanding its role in inflammation and the immune response. This research could potentially lead to new treatments for inflammatory skin diseases and other conditions associated with IL36G.
See Also[edit]
- Interleukin
- Interleukin-1
- NF-kappaB
- Psoriasis
- Eczema
- Rheumatoid arthritis
- Inflammatory bowel disease
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
